Trish Webster died of acute gastrointestinal illness after several months of taking Ozempic and Saxenda Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in ...

Saxenda (liraglutide) and Ozempic (semaglutide) are brand-name solutions for subcutaneous injection. Saxenda is approved for weight management. Doctors may prescribe Ozempic off-label for this ...

The Danish drugmaker's new 3 mg formulation, which, when approved, will be marketed as Saxenda, has been given a positive opinion as an adjunct to a reduced-calorie diet and increased physical ...

European regulators have recommended an update to the label of Novo Nordisk’s weight loss drug, Saxenda, to include information about the active ingredient’s ability to reduce cardiovascular risk.

is pleased to announce that dosing has begun as scheduled in its human study GLP-1-H25-5 (the "Study") that is comparing oral DehydraTECH-liraglutide to injected Saxenda®-branded liraglutide.